[Suppression of exocrine secretion does not lead to disruption of endocrine function of pancreas transplants].
The adequate management of the exocrine secretion of vascularized pancreas transplants is still controversial. Basically, the exocrine graft secretion may either be suppressed by obstruction of the pancreatic ducts or preserved by drainage into the recipient's enteric or urinary tract. In a model of isogenic pancreas transplantation in streptozotocin diabetic rats the impact of preserved versus suppressed exocrine secretion on the quality of endocrine graft function was investigated. Preservation of the exocrine secretion was accomplished by pancreaticoduodenal transplantation, while duct ligation was used to suppress the exocrine secretion. Endocrine graft function was monitored by determination of non-fasting blood glucose levels, intravenous glucose tolerance tests, peripheral insulin levels, water and food intake as well as urine and faeces production. Suppression of the exocrine graft secretion induced acinar atrophy, proliferation of pancreatic ducts, interstitial cell infiltration and fragmentation of islets of Langerhans, while drainage of the exocrine graft secretion completely preserved the architecture of the transplant. Despite the fundamental structural changes induces by exocrine suppression no deterioration of endocrine graft function was noted within the observation period of one year. Both techniques were equally effective in ameliorating the diabetic hyperglycemia, hypoinsulinemia, reduced glucose tolerance, polydipsia, polyphagia, polyuria and restored normal growth rate and general health of diabetic pancreas graft recipients. Thus it can be concluded that suppression of the exocrine secretion does not impair the quality of endocrine function of pancreas transplants.
Klempnauer
J
J
Abteilung für Abdominal- und Transplantationschirurgie, Medizinischen Hochschule Hannover.
Lück
R
R
Brüsch
U
U
Steiniger
B
B
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D007328:Insulin / Q000097:blood*; D007515:Islets of Langerhans / Q000378:metabolism* / Q000473:pathology; D008297:Male; D010179:Pancreas / Q000473:pathology; D016035:Pancreas Transplantation / Q000379:methods*; D010183:Pancreatic Ducts / Q000601:surgery*; D010186:Pancreatic Function Tests; D051381:Rats; D011917:Rats, Inbred Lew; D014945:Wound Healing / Q000502:physiology
D001786:Blood Glucose; D007328:Insulin
Die Unterdrückung der exokrinen Sekretion führt zu keiner Beeinträchtigung der endokrinen Funktion von Pankreastransplantaten.